UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012943
Receipt No. R000015136
Scientific Title Phase I Dose-escalation, Safety / Tolerability and Preliminary Efficacy Study of Intratumoral Administration of GEN0101 in Patients with Advanced Melanoma.
Date of disclosure of the study information 2014/03/01
Last modified on 2017/01/17 14:35:28

No. Disposal Last modified on Item of update
1 Insert 2014/01/24 16:45:35
2 Update 2014/07/28 10:05:15 Key exclusion criteria
Key exclusion criteria
3 Update 2015/01/06 13:48:17 Recruitment status
Anticipated trial start date
4 Update 2015/09/11 13:02:08 Basic objectives2
5 Update 2015/09/11 13:27:40 Key inclusion criteria
Key exclusion criteria
6 Update 2015/09/11 13:31:31 Organization
Organization
7 Update 2015/09/11 13:53:54 Category of Funding Organization
8 Update 2016/08/02 09:53:58 Key exclusion criteria
9 Update 2016/08/02 09:57:07 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
10 Update 2017/01/17 14:35:28 Recruitment status


Contact us.